Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$337,457
-$56,056 QoQ
Shares Held
14,014
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,038
of 2,821 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SYKON CAPITAL LLC holds $1,340,935 across 2 Drug Manufacturers - General names. PFE ranks #2 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
6,403 | $1,003,478 | |
| 2 | PFE |
Pfizer Inc
This page
|
14,014 | $337,457 |
All Filings in PFE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,457 | 14,014 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $393,513 | 14,014 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $348,948 | 14,014 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $357,076 | 14,014 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $291,219 | 12,014 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $304,434 | 12,014 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $318,731 | 12,014 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $347,685 | 12,014 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $336,151 | 12,014 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $333,388 | 12,014 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $345,883 | 12,014 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $398,504 | 12,014 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $466,019 | 12,705 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||